Latest News

Late Breaking News Articles

Filter by:
Topic
Clear filter
An image of Acute Myeloid Leukemia cells
HOPA News Late Breaking News

Late-Breaking HOPA News: The Evolving Landscape of NPM1-Mutated AML

November 24, 2025

Moh'd Mohanad A. Al-Dabet, PhD, AHI(AMT); Katia Al-Sawalha, BSc; and Olivia White, PharmD, BCOP, review revumenib and ziftomenib for NPM-1m disease and highlight key considerations when implementing these two therapies.

An image of a lung inside the body
HOPA News Late Breaking News

Late-Breaking HOPA News: Lurbinectedin and Atezolizumab for Extensive-Stage Small Cell Lung Cancer

September 30, 2025

Ming-Hei Tai, PharmD, BCOP, and Alexis Chapman, PharmD, BCOP, discuss the IMforte trial concerning lurbinectedin and atezolizumab in the treatment of extensive-stage small cell lung cancer.

Pharmacist with technology
HOPA News Late Breaking News

Late-Breaking HOPA News: AI Integration in Pharmacy

May 07, 2025

Aracely Sosa, PharmD; Katelyn Toeniskoetter, PharmD, BCOP; and Pearl Abraham, PharmD, BCPS, BCOP, dive into the basics and beyond of AI integration in pharmacy.

Diffuse large B-cell lymphoma
HOPA News Late Breaking News

Late-Breaking HOPA News: The Emerging Use of Bispecific Antibodies with Chemotherapy in Diffuse Large B-Cell Lymphoma

April 29, 2025

Katelynn Granger, PharmD, BCOP, and Matthew Warrick, PharmD, BCPS, BCOP, dive into the emerging use of bispecific antibodies with chemotherapy in diffuse large B-cell lymphoma.

Woman diagnosing breast cancer
HOPA News Late Breaking News

Late-Breaking HOPA News: Fam-trastuzumab deruxtecan-nxki for HER2 Ultralow Metastatic Breast Cancer

January 10, 2025

The ability of fam-trastuzumab deruxtecan-nxki to treat breast cancer patients with HER2 IHC 0 with positive membrane staining up to IHC 3+ has changed the treatment paradigm for metastatic disease.

Breast cancer ribbon image
HOPA News Late Breaking News

Late-Breaking HOPA News: Ribociclib in the Adjuvant Setting for Early-Stage High Risk HR-Positive, HER2-Negative Breast Cancer

December 23, 2024

Clarissa Wilkins, PharmD, BCOP, and Anne DeLisa, PharmD, CCRP, dive deeper into ribociclib (Kisqali) after its FDA approval in September 2024.

IV bag
HOPA News Late Breaking News

Late-Breaking HOPA News: Navigating the Nationwide IV Fluid Shortage and Its Toll on Oncology Care

December 19, 2024

Ashley Jones, PharmD, BCOP; Sanja Zepcan, PharmD; and Emily Rux, PharmD, BCOP, discuss the impact of current nationwide IV fluid shortages.

Oncology Stewardship
Late Breaking News

Oncology Stewardship Practice in the United States: A Hematology/Oncology Pharmacy Association National Survey

November 26, 2024

A recently published survey looks to gain insight on the current landscape of oncology stewardship in the United States.

Late Breaking News

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

September 20, 2024

A recently published article details the impact of having an inpatient clinical oncology pharmacy technician program.

Visual of data being collected
Late Breaking News

Oncology Pharmacy Staffing Survey Across Practice Settings in the United States

September 19, 2024

The results of a recently published pharmacy staffing model survey has brought new insights into oncology pharmacy operations across the country.

LED sign that reads CAR T Cells
HOPA News Late Breaking News

Late-Breaking HOPA News: CAR-T Approval Updates

July 22, 2024

CAR-T approval updates show the treatment moving up the rung in Multiple Myeloma and breaking ground in Chronic Lymphocytic Leukemia

Early-Stage Non-small Cell Lung Cancer
Late Breaking News

Late-Breaking HOPA News: Adjuvant Alectinib in Early-Stage Non-small Cell Lung Cancer (NSCLC)

June 12, 2024

In April 2024, the FDA approved alectinib (Alecensa®) in patients with early-stage ALK-positive non-small cell lung cancer (NSCLC) based on the ALINA trial.